<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04677699</url>
  </required_header>
  <id_info>
    <org_study_id>WSIRB# 2020-078</org_study_id>
    <nct_id>NCT04677699</nct_id>
  </id_info>
  <brief_title>Combined Antibody Screening for Celiac and Diabetes Evaluation</brief_title>
  <acronym>CASCADE</acronym>
  <official_title>Combined Antibody Screening for Celiac and Diabetes Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pacific Northwest Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Exeter</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Pacific Northwest Research Institute</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The CASCADE Study (Combined Antibody Screening for Celiac and Diabetes Evaluation) is an&#xD;
      observational study whose primary goal is to show that population-based screening for&#xD;
      advanced prediction of type 1 diabetes (T1D) and celiac disease (CD) is feasible to prevent&#xD;
      diabetic ketoacidosis (DKA), improve celiac disease diagnosis, and ultimately gain public&#xD;
      health acceptance to facilitate future prevention. It has two arms, a Birth Cohort and a Kids&#xD;
      (cross sectional) Cohort.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">December 2020</start_date>
  <completion_date type="Anticipated">June 2026</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnosis of Type 1 Diabetes</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Diagnosis of Celiac Disease</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severity of disease at diagnosis</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">64410</enrollment>
  <condition>Type 1 Diabetes</condition>
  <condition>Celiac Disease</condition>
  <arm_group>
    <arm_group_label>Birth Cohort</arm_group_label>
    <description>Newborns less than 8 months old and born in the state of Washington.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Kids Cohort</arm_group_label>
    <description>Children ages 4-7 years and born in the state of Washington.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Combined Risk Score</intervention_name>
    <description>Several factors will be analyzed to assign each subject combined risk score. This will assess the subject's risk of developing Type 1 Diabetes and/or Celiac Disease.</description>
    <arm_group_label>Birth Cohort</arm_group_label>
    <arm_group_label>Kids Cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Newborns and school aged children in the state of Washington.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Child must be between 0 to 8 months in age or between 4 to 7 years in age. Child must&#xD;
             be born in the state of Washington.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William Hagopian, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pacific Northwest Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pacific Northwest Research Institute</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 16, 2020</study_first_submitted>
  <study_first_submitted_qc>December 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 21, 2020</study_first_posted>
  <last_update_submitted>December 16, 2020</last_update_submitted>
  <last_update_submitted_qc>December 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pacific Northwest Research Institute</investigator_affiliation>
    <investigator_full_name>William Hagopian</investigator_full_name>
    <investigator_title>Director of Diabetes Program</investigator_title>
  </responsible_party>
  <keyword>Type 1 Diabetes</keyword>
  <keyword>Celiac Disease</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Celiac</keyword>
  <keyword>Gluten</keyword>
  <keyword>Autoantibodies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Celiac Disease</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

